TABLE 2.
Patient and Tumor Characteristics | Adjusted Risk Ratio | 95% Confidence Interval |
---|---|---|
Type of endometrial sampling | ||
With hysteroscopy | 3.03 | (1.43, 6.42) |
Without hysteroscopy | Reference | |
Age | ||
18–54 years | Reference | |
≥55 years | 1.00 | (0.64, 1.54) |
Race/Ethnicity | ||
Non-Hispanic White | 1.00 | (0.66, 1.50) |
Other/Unknown | Reference | |
Cancer stage | ||
Localized | 0.50 | (0.28, 0.89) |
Regional | 0.60 | (0.35, 1.05) |
Distant | Reference | |
Cancer grade | ||
1–3 | Reference | |
4 | 1.35 | (0.90, 2.03) |
Unknown | 1.06 | (0.61, 1.84) |
Tumor size | ||
<8 cm | Reference | |
8–11 cm | 0.82 | (0.49, 1.38) |
>11 cm | 0.54 | (0.30, 0.99) |
Unknown | 1.36 | (0.82, 2.24) |
Presence of a diagnosis code for leiomyoma | ||
Yes | 0.92 | (0.62, 1.36) |
No | Reference | |
Postmenopausal bleeding | ||
Yes | 1.13 | (0.70, 1.81) |
No | Reference | |
Premenopausal menorrhagia/frequent Menstruation | ||
Yes | 0.78 | (0.42, 1.47) |
No | Reference |